APA citiranje

Shields, B. D., Koss, B., Taylor, E. M., Storey, A. J., West, K. L., Byrum, S. D., . . . Tackett, A. J. (2019). Loss of E-cadherin inhibits CD103 anti-tumor activity and reduces checkpoint blockade responsiveness in melanoma. Cancer Res.

Citação norma Chicago

Shields, Bradley D., et al. "Loss of E-cadherin Inhibits CD103 Anti-tumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma." Cancer Res 2019.

MLA citiranje

Shields, Bradley D., et al. "Loss of E-cadherin Inhibits CD103 Anti-tumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma." Cancer Res 2019.